Detalhe da pesquisa
1.
Enasidenib vs conventional care in older patients with late-stage mutant-IDH2 relapsed/refractory AML: a randomized phase 3 trial.
Blood
; 141(2): 156-167, 2023 01 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35714312
2.
Siglec-6 is a novel target for CAR T-cell therapy in acute myeloid leukemia.
Blood
; 138(19): 1830-1842, 2021 11 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34289026
3.
Deep MRD profiling defines outcome and unveils different modes of treatment resistance in standard- and high-risk myeloma.
Blood
; 137(1): 49-60, 2021 01 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32693406
4.
Transcriptional and genomic characterization of measurable residual disease in acute myeloid leukaemia.
Br J Haematol
; 201(6): 1239-1244, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37057357
5.
Basophil-lineage commitment in acute promyelocytic leukemia predicts for severe bleeding after starting therapy.
Mod Pathol
; 31(8): 1318-1331, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29572500
6.
Immune status of high-risk smoldering multiple myeloma patients and its therapeutic modulation under LenDex: a longitudinal analysis.
Blood
; 127(9): 1151-62, 2016 Mar 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-26668134
7.
Phenotypic and genomic analysis of multiple myeloma minimal residual disease tumor cells: a new model to understand chemoresistance.
Blood
; 127(15): 1896-906, 2016 Apr 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-26755711
8.
Phenotypic, transcriptomic, and genomic features of clonal plasma cells in light-chain amyloidosis.
Blood
; 127(24): 3035-9, 2016 06 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-27069257
9.
Minimal residual disease monitoring and immune profiling in multiple myeloma in elderly patients.
Blood
; 127(25): 3165-74, 2016 06 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-27118453
10.
Critical analysis of the stringent complete response in multiple myeloma: contribution of sFLC and bone marrow clonality.
Blood
; 126(7): 858-62, 2015 Aug 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-26089396
11.
The cellular origin and malignant transformation of Waldenström macroglobulinemia.
Blood
; 125(15): 2370-80, 2015 Apr 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-25655603
12.
Recovery of polyclonal immunoglobulins one year after autologous stem cell transplantation as a long-term predictor marker of progression and survival in multiple myeloma.
Haematologica
; 102(5): 922-931, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28126960
13.
Multiparameter flow cytometry for staging of solitary bone plasmacytoma: new criteria for risk of progression to myeloma.
Blood
; 124(8): 1300-3, 2014 Aug 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-24876564
14.
Bortezomib, thalidomide and dexamethasone, with or without cyclophosphamide, for patients with previously untreated multiple myeloma: 5-year follow-up.
Br J Haematol
; 171(3): 344-54, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26153365
15.
Detailed characterization of multiple myeloma circulating tumor cells shows unique phenotypic, cytogenetic, functional, and circadian distribution profile.
Blood
; 122(22): 3591-8, 2013 Nov 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-24072855
16.
Panobinostat as part of induction and maintenance for elderly patients with newly diagnosed acute myeloid leukemia: phase Ib/II panobidara study.
Haematologica
; 100(10): 1294-300, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26160880
17.
High-risk cytogenetics and persistent minimal residual disease by multiparameter flow cytometry predict unsustained complete response after autologous stem cell transplantation in multiple myeloma.
Blood
; 119(3): 687-91, 2012 Jan 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-22128143
18.
Multiparameter flow cytometry evaluation of plasma cell DNA content and proliferation in 595 transplant-eligible patients with myeloma included in the Spanish GEM2000 and GEM2005<65y trials.
Am J Pathol
; 181(5): 1870-8, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-22974582
19.
The clinical utility and prognostic value of multiparameter flow cytometry immunophenotyping in light-chain amyloidosis.
Blood
; 117(13): 3613-6, 2011 Mar 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-21266717
20.
Outcome according to cytogenetic abnormalities and DNA ploidy in myeloma patients receiving short induction with weekly bortezomib followed by maintenance.
Blood
; 118(17): 4547-53, 2011 Oct 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-21900193